ILK and carcinoma: To ensure that the exogenous expression of the different proteins mentioned above (e.g., FAK, ILK, etc.)did not contribute to FA stability, we expressed them in U2-OS human carcinoma cells without coexpressing active forms of vinculin and under tension-releasing drugs.